Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-Vegf Therapy in Fighting Metastatic Colorectal Cancer?

Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2017.10.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Tumour-Infiltrating Neutrophils Counteract Anti-Vegf Therapy in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Chronic Mucocutaneous Candidiasis Associated With a Novel Frameshift Mutation in IL-17 Receptor Alpha (IL-17RA)

LymphoSign Journal
2019English

IL-17, IL-27, and IL-33: A Novel Axis Linked to Immunological Dysfunction During Sepsis

Frontiers in Immunology
AllergyImmunology
2019English

Targeting IL-17B–IL-17RB Signaling With an Anti–IL-17rb Antibody Blocks Pancreatic Cancer Metastasis by Silencing Multiple Chemokines

Journal of Experimental Medicine
MedicineAllergyImmunology
2015English

HER2 Gene Copy Number Status May Influence Clinical Efficacy to Anti-Egfr Monoclonal Antibodies in Metastatic Colorectal Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2013English

Radiolabeled Monoclonal Antibodies in the Treatment of Metastatic Cancer

Current Oncology
Oncology
2007English

Glycosphingolipids MediatePneumocystisCell Wall Β-Glucan Activation of the IL-23/IL-17 Axis in Human Dendritic Cells

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2012English

High Antitumor Activity of RLI, an Interleukin-15 (IL-15)-IL-15 Receptor Fusion Protein, in Metastatic Melanoma and Colorectal Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Hepatitis B Virus Induces IL-23 Production in Antigen Presenting Cells and Causes Liver Damage via the IL-23/IL-17 Axis

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy